Title: Marketing of Clozaril
First published: 1991
Subjects: Clozapine, Cost control, Drugs, Marketing, Medical care, Prices, Sandoz Pharmaceuticals Corporation, Drug accessibility, Whistle blowing, United States, United States. Federal Grain Inspection Service
Places: United States
LC classification: KF26 .J835 1991